Finecure Pharmaceuticals manufactures 250+ commercialized formulations across seven therapeutic verticals, produced at four manufacturing sites under WHO-GMP standards. Each product page states the molecule and strength, the dosage form, the manufacturing line and its applicable accreditations, and the pharmacopoeial or in-house specification the product is released against.
The portfolio serves two channels from one quality system. In India it supports a branded prescription business reaching 40,000+ prescribing practitioners and 80,000+ pharmacies. Internationally it supplies 20+ markets including North America, Africa, WANA, South East Asia and Latin America, backed by 100+ product registrations and CTD / eCTD / ACTD dossier support. Products are available for import supply, institutional and tender participation, out-licensing, and contract manufacture.
Our DSIR-approved R&D center continuously executes complex technology transfers and formulation development. If your required therapeutic is not listed in our active commercial matrix, contact our technical team to initiate a custom Contract Manufacturing (CDMO) project.
Submit CDMO / Tech-Transfer Inquiry
